The fourth volume in this series is a proceedings volume based on papers presented at the 5th Innovations in Regenerative Medicine and Cancer Research conference. Chapters are written by some of the most innovative minds in stem cell and tissue engineering research, and provide a comprehensive overview of papers from the most recent conference. The volume addresses tissue engineering principles and applications, including current trends and challenges, as well as future directions. Cutting edge topics of interest include production of functional tissues, vascularization and immune responses,…mehr
The fourth volume in this series is a proceedings volume based on papers presented at the 5th Innovations in Regenerative Medicine and Cancer Research conference. Chapters are written by some of the most innovative minds in stem cell and tissue engineering research, and provide a comprehensive overview of papers from the most recent conference. The volume addresses tissue engineering principles and applications, including current trends and challenges, as well as future directions. Cutting edge topics of interest include production of functional tissues, vascularization and immune responses, and functionalization of scaffolds. Volumes in this series are invaluable resources for active researchers, clinicians, and professionals in industry, as well as students across a broad range of fields.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Phuc Van Pham received his Ph.D. in Human Physiology from Viet Nam National University, Ho Chi Minh City, Viet Nam. He is currently a Professor of Biology at Viet Nam National University and Director of Stem Cell Institute. He is a longstanding lecturer and translational scientist at the University, and is a member of several societies and journal editorial boards focused on stem cells as well as immunotherapy. Dr. Pham and his colleagues have established one of the first multidisciplinary stem cell centers in Viet Nam, and he has successfully launched an array of technologies in stem cell and immune cell therapy. His research interests include stem cell isolation, stem cell therapy, mesenchymal stem cells, cancer stem cells, immunotherapy and regenerative medicine and he has published extensively in these areas. After many years of experience as an embryologist, cell biologist, and molecular biologist, collaborating with leading researchers in Singapore, Japan, and the United States, Dr. Pham is a student again, keen to reach beyond the traditional boundaries of biology.
Inhaltsangabe
Session 1: Advances in Mesenchymal Stem Cell Biology and Therapy.- Hypoxia, Serum Starvation, and TNF- Can Modify the Immunomodulation Potency of Human Adipose-Derived Stem Cells.- Interferon-Gamma Increases the Immune Modulation of Umbilical Cord-Derived Mesenchymal Stem Cells but Decreases Their Chondrogenic Potential.- Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Angiogenesis Through Upregulation of the VWF and Flk1 Genes in Endothelial Cells.- Stromal Vascular Fraction and Mesenchymal Stem Cells from Human Adipose Tissue: A Comparison of Immune Modulation and Angiogenic Potential.- Routes of Stem Cell Administration.- Optimal Delivery Route of Mesenchymal Stem Cells for Cardiac Repair: The Path to Good Clinical Practice.- Intravenous Infusion of Exosomes Derived from Human Adipose Tissue-Derived Stem Cells Promotes Angiogenesis and Muscle Regeneration: An Observational Study in a Murine Acute Limb Ischemia Model.- Session 2: Advances in Tissue Engineering.- Bone Using Stem Cells for Maxillofacial Bone Disorders: A Systematic Review and Meta-analysis.- Tissue Engineering for Tracheal Replacement: Strategies and Challenges.- The Rapid Development of Airway Organoids: A Direct Culture Strategy.- A Simple Method to Produce Engineered Cartilage from Human Adipose-Derived Mesenchymal Stem Cells and Poly -Caprolactone Scaffolds.- Culture and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Growth Factor-Rich Fibrin Scaffolds to Produce Engineered Cartilages.- Treatment of Osteochondral Femoral Head Defect by Human Umbilical Cord Mesenchymal Stem Cell Sheet Transplantation: An Experimental Study in Rats.
Session 1: Advances in Mesenchymal Stem Cell Biology and Therapy.- Hypoxia, Serum Starvation, and TNF- Can Modify the Immunomodulation Potency of Human Adipose-Derived Stem Cells.- Interferon-Gamma Increases the Immune Modulation of Umbilical Cord-Derived Mesenchymal Stem Cells but Decreases Their Chondrogenic Potential.- Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Angiogenesis Through Upregulation of the VWF and Flk1 Genes in Endothelial Cells.- Stromal Vascular Fraction and Mesenchymal Stem Cells from Human Adipose Tissue: A Comparison of Immune Modulation and Angiogenic Potential.- Routes of Stem Cell Administration.- Optimal Delivery Route of Mesenchymal Stem Cells for Cardiac Repair: The Path to Good Clinical Practice.- Intravenous Infusion of Exosomes Derived from Human Adipose Tissue-Derived Stem Cells Promotes Angiogenesis and Muscle Regeneration: An Observational Study in a Murine Acute Limb Ischemia Model.- Session 2: Advances in Tissue Engineering.- Bone Using Stem Cells for Maxillofacial Bone Disorders: A Systematic Review and Meta-analysis.- Tissue Engineering for Tracheal Replacement: Strategies and Challenges.- The Rapid Development of Airway Organoids: A Direct Culture Strategy.- A Simple Method to Produce Engineered Cartilage from Human Adipose-Derived Mesenchymal Stem Cells and Poly -Caprolactone Scaffolds.- Culture and Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Growth Factor-Rich Fibrin Scaffolds to Produce Engineered Cartilages.- Treatment of Osteochondral Femoral Head Defect by Human Umbilical Cord Mesenchymal Stem Cell Sheet Transplantation: An Experimental Study in Rats.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826